SmartSkin Seal Assurance ISPE Launch

SmartSkin Launches Pharma Seal Assurance Solution to Deliver Real-Time Insights into Container Closure Integrity and Capping Performance

Published On: December 2, 2025

SmartSkin’s ISPE 4.0 debut redefines seal quality in pharma manufacturing.

Fredericton, NB – December 1st, 2025 – SmartSkin Technologies, a leader in pharmaceutical manufacturing intelligence, today announced the availability of SmartSkin Seal Assurance, a breakthrough solution that gives pharmaceutical manufacturers real-time visibility into seal tightness leading to Container Closure Integrity across vial and cartridge capping. SmartSkin will debut the technology at the upcoming ISPE 4.0 in Barcelona, Spain, highlighting how analytics advance seal quality and reliability in pharmaceutical manufacturing.

SmartSkin Seal Assurance provides per-head, real-time feedback on sealing performance by measuring and visualizing forces during capping. Each event generates a digital signature, creating auditable proof that every capper head is configured and operating within specification. This record helps confirm setup quality and consistency. Compatible with single and multi-head systems, it complements Residual Seal Force (RSF) testing by confirming that sealing conditions measured in RSF are established from the start, closing the loop on Container Closure Integrity assurance.

“Despite the critical importance of seal quality for sterile products, translating the mechanical settings of capping equipment into the physical seal characteristics needed for container-closure performance has not been possible…until now,” said Dr. Mihaela Simianu, Scientific Advisor at SmartSkin Technologies. “SmartSkin’s Seal Assurance opens the possibilities to proactively build container closure integrity assurance into the aseptic process design, creating new possibilities to enhance equipment and process performance in measurable, controllable, and reliable ways

SmartSkin Seal Assurance Launch ISPE

A recent implementation with one of the world’s largest pharma manufacturers demonstrated Seal Assurance’s ability to detect head-specific inconsistencies and identify optimal capping parameters, validating its role as a proactive control solution that enhances both quality and efficiency.

Seal Assurance supports applications from factory acceptance testing (FAT/SAT) and line qualification to routine setup verification and troubleshooting.

About SmartSkin Technologies

SmartSkin Technologies delivers manufacturing intelligence solutions that enable pharmaceutical producers to ensure quality, enhance patient safety, and eliminate costly production issues. By combining advanced Digital Container Twins with real-time analytics, SmartSkin helps manufacturers identify risks, prevent defects, and drive continuous improvement across complex fill-finish and packaging operations. Trusted by global leaders like Schott, Pfizer, and Sanofi, SmartSkin provides the precision and visibility needed to achieve zero-defect production and uphold the highest standards of pharmaceutical manufacturing excellence. Learn more at www.smartskintech.com.

Media Contact

Kumaran Thillainadarjah
Founder and Chief Technology Officer, SmartSkin Technologies
kumaran.t@smartskintech.com
+1 (855) 210-9006

Related Posts

SmartSkin Year End Review 2025

SmartSkin – Year-End Review 2025

As the year draws to a close, we’re taking a moment to reflect on the milestones that shaped our journey. From engaging with industry leaders at global events and hosting insightful webinars, to earning recognition through prestigious award nominations and wins, this year has been defined by progress, collaboration, and impact. This year in review […]
Austin Caudle SmartSkin Technologies PDA Board of Directors

Interview with Austin Caudle: Strengthening Collaboration and Innovation in Pharma

The Parenteral Drug Association (PDA) has long played a vital role in connecting professionals across the pharmaceutical industry — advancing quality, innovation, and regulatory collaboration. Recently, Austin Caudle, Vice President of Business Development – Pharmaceutical at SmartSkin Technologies, was nominated to serve on PDA’s 2026 Board of Directors. We sat down with Austin to discuss […]